CIRCULATION JOURNAL, vol.72, no.1, pp.61-66, 2008 (SCI-Expanded)
Background Current evidence supports the central role of inflammation in all phases of the atherosclerotic process, including its thrombotic complications. Increased serum sCD40L may trigger platelet activation, so the aim of the present study was to determine the relation between sCD40L levels and aspirin-resistant platelet aggregation in patients with coronary atherosclerosis.